Balance Sheet Data

Surface Oncology, Inc. (SURF)

$0.6327

-0.03 (-4.14%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 158.83105.16175.14154.15124.822,135.9910,497.5151,590.93253,548.121,246,084.40
Total Cash (%)
Account Receivables 0.320.342.570.040.482.3411.5256.61278.211,367.29
Account Receivables (%)
Inventories ----------
Inventories (%)
Accounts Payable 3.413.381.670.262.9114.3070.29345.431,697.668,343.28
Accounts Payable (%)
Capital Expenditure -2.02-1.54-0.04-0.12-0-5.28-25.96-127.57-626.93-3,081.12
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.